Higher-Strength Anti-Vertigo Agent: This 24 mg formulation provides a more potent dose of Betahistine, a synthetic histamine analog used for advanced management of inner ear balance issues. Core Clinical Indications: It is explicitly prescribed to prevent and treat symptoms of Ménière's disease, including disabling vertigo (spinning dizziness), tinnitus (constant ear ringing), and associated hearing loss. About the Company Legal Status of Firm: Limited Company Number of Employees: Upto 10 People Annual Turnover: 0 - 40 L